The most commonly used and extensively researched minimally invasive treatment methods are applied to malignant tumours of the liver and to liver metastases – a piece of medical good fortune, since the liver is very often the key organ for prognosis in cases of tumours.

Only a minority of patients with primary liver tumours, bile duct cancer, or secondary liver tumours (metastases) are suitable for surgical treatment. In most cases, the number of tumours, their location, or other existing health conditions preclude surgery. Occasionally, new tumours also develop in the residual liver tissue following the surgical removal of cancerous tissue (recurrences).

To reduce the size of these unmet therapeutic needs, multiple minimally invasive methods were developed over the last two decades, and these allow the targeted destruction of liver tumours while preserving the healthy liver tissue.

We choose the most appropriate method based on the patient’s individual state of health. Of major importance in this context are the location, number, vascular supply, and size of the tumours within the liver, but also any pre-existing conditions, previous treatments, and so on.

Talk to us about your situation.

Inactivation of liver tumours using gamma radiation – introduced via microspheres
> Selective Internal Radiation Therapy (SIRT)

Inactivation of liver tumours using gamma rays – administered via catheter
> Brachytherapie

Inactivation of liver tumours using heat – administered via a needle electrode
> Radio-Frequenz-Ablation (RFA)

Inactivation of liver tumours using chemotherapy – administered via catheter
> Transarterielle Chemo-Embolisation (TACE)


Minimally Invasive Tumour Therapy (MITT)
Charité Campus Virchow-Klinikum (CVK)
Department of Radiology
Augustenburger Platz 1
13353 Berlin